StanisicS., BertolottoA., BertoP., Di ProcoloP., and MorawskiJ. “The Cost-Effectiveness of Alemtuzumab in the Management of Relapse-Remitting Multiple Sclerosis in Italy”. Global & Regional Health Technology Assessment, Vol. 6, no. 1, Apr. 2019, doi:10.33393/grhta.2019.465.